Embodiments of the present disclosure relate to devices for accessing a blood vessel by creating an opening through a wall of the blood vessel, and for subsequently closing the opening, and related methods of use.
Various mechanisms are available for accessing a blood vessel in order to perform a medical procedure inside the blood vessel or other part of the cardiovascular system. However, many conventional techniques position a sheath or other member within the blood vessel, restricting the field of view within the vessel, and restricting the ability to navigate tools both proximally and distally of the point of insertion. Additionally, procedure times for conventional techniques may be higher than optimal.
In one aspect, the disclosure is directed to a medical device including an outer assembly having a first shaft, a first lumen extending through the first shaft, and an atraumatic first tip removably coupled to a distal end of the first shaft; an inner assembly configured to extend through the first lumen of the outer assembly, the inner assembly including a second shaft, a second lumen extending through the second shaft, and a second tip removably coupled to a distal end of the second shaft, the second tip being configured to pierce tissue; and a plug assembly configured to extend through the second lumen of the inner assembly, the plug assembly including a third shaft and a plug removably coupled to a distal end of the third shaft.
The first tip may include a first tip lumen, the second tip may extend through the first tip lumen, and the second tip may include a protrusion configured to engage with the first tip and secure the first tip to the second tip. The protrusion may extend proximally from a proximal end of the second tip, and is configured to engage with a proximal end of the first tip via a snap-fit. The first tip may include a first bevel at a distal end of the first tip. The second tip may include a second bevel configured to pierce tissue at a distal end of the second tip. The second tip may include a first flange extending proximally from the second bevel at an angle offset from a longitudinal axis of the second tip. The first flange may include a first part and a second part pivotable relative to the first part by a hinge. In a first configuration, the second part may extend at a first angle to the longitudinal axis of the second tip, and in a second configuration, the second part may extend at a second angle to the longitudinal axis of the second tip, wherein the second angle is different than the first angle. Pulling the inner assembly proximally may cause the second part to pivot from the first configuration to the second configuration. The hinge may be a living hinge. The second tip may include a second tip lumen extending through the second tip, an inner surface surrounding a distal portion of the second tip lumen, and a second flange extending radially inward from the inner surface and surrounding a proximal portion of the second tip lumen. The plug may be a solid member without lumens, may include a bevel at a distal end, and may include a third flange extending circumferentially around a portion of the plug, wherein a distally-facing surface of the third flange is configured to abut a proximal-facing surface of the second flange when the plug is extended through the second lumen. The second tip may include a recess at a distal end of the second tip, the recess extending only partially around a circumference of the second tip, and the plug may include a protrusion configured to be received by the recess, the protrusion extending only partially around a circumference of the plug. One or more of the first tip, the second tip, and the plug may be bioresorbable. Each of the first tip, the second tip, and the plug may be bioresorbable.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate various exemplary embodiments and together with the description, serve to explain the principles of the disclosed embodiments.
Reference will now be made in detail to exemplary embodiments of the present disclosure, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts or components. The term “distal” refers to the direction that is away from the user or operator and into the patient's body. By contrast, the term “proximal” refers to the direction that is closer to the user or operator and away from the patient's body.
The present disclosure is directed to devices for accessing a blood vessel, such as, e.g., a femoral artery, a carotid artery, or any other artery or vein. An exemplary method is shown in
Referring to
Various portions of inner assembly 100 are shown in
Piercing tip 108 has a body that extends from a proximal end 109 to a distal end 110, and may include a bevel 111 at distal end 110 that is configured to pierce through tissue. Piercing tip 108 also may include a flange 112 that extends proximally from bevel 111. In some examples, flange 112 may lie in the same plane as bevel 111. In some examples, flange 112 extends from only a proximal portion of bevel 111. Flange 112, and particularly its proximal-facing surface, may include a tacky coating and/or bioadhesive to help maintain flange 112 against tissue. A lumen 113 may extend from proximal end 109 to distal end 110. Piercing tip 108 may include a circumferential rim 114 at proximal end 109, and a circumferential flange 116 disposed distally of rim 114. The flange 116 may extend radially inward from an inner surface 118 of piercing tip 108. The flange 116 may have a smaller diameter than rim 114. A locking arm 120 may extend proximally from rim 114. Locking arm 120 may include a radially-outward extending protrusion 121. Piercing tip 108 also may include a recess 122 at distal end 110, which may be used in a snap fit engagement with a portion of plug assembly 300, as discussed in further detail below. Piercing tip 108 also may include one or more openings 124 extending through its body and in communication with lumen 113. In one example, piercing tip 108 may include diametrically opposed openings 124 that align with openings 110 of shaft 106.
Piercing tip 108 may be coupled to a distal end of shaft 106 via a connecting member 130. The connecting member 130 may extend outside of the one or more lumens of shaft 106 and through openings 110 of shaft 106 and openings 124 of piercing tip 108, to secure the piercing tip 108 to shaft 106. The connecting member 130 may be a suture, wire, thread, or other suitable connecting member. Opposing ends 132 of connecting member 130 may extend proximally when piercing tip 108 and shaft 106 are coupled to one another. In one example, tension may be applied to those ends 132. Piercing tip 108 may be configured to detach from shaft 106. In one example, tension may be released from one of the ends 132, allowing connecting member 130 to be removed from the device by pulling on the other end 132. In another example, connecting member 130 may include one or more frangible links that are configured to break when a sufficient pulling force is applied to ends 132, allowing separation of piercing tip 108 from shaft 106.
Referring to
Various portions of outer assembly 200 are shown in
Distal tip 208 has a body that extends from a proximal end 209 to a distal end 210, and may include a bevel 211 at distal end 210 that is configured to clamp onto tissue. In some examples, the bevel 211 may be atraumatic to prevent excessive damage to tissue when used as a clamp. Bevel 211 may include a tacky coating and/or bioadhesive in order to help secure bevel 211 against tissue. A gauze or other fabric may be coupled to bevel 211 to absorb excess bodily fluids and to facilitate healing during closure of an access opening to a blood vessel. Proximal end 209 may include a generally cylindrical portion 215 configured to slide into a lumen of shaft 206. Distal tip 208 also may include a proximally-facing circumferential flange 212 configured to abut the distal end of shaft 206. A lumen 213 may extend from proximal end 209 to distal end 210. Distal tip 208 also may include one or more openings 224 extending through cylindrical portion 215 and in communication with lumen 213. In one example, distal tip 208 may include diametrically opposed openings 224 that align with openings 210 of shaft 206.
Distal tip 208 may be coupled to a distal end of shaft 206 via a connecting member 130 that is substantially similar to the connecting member 130 previously described. The connecting member 130 may extend through openings 224 of distal tip 208 and at least partially around a circumference of cylindrical portion 215. The ends 132 of the connecting member 130 then may be passed through openings 210 of shaft 206, the lumen of shaft 206, and proximally out of shaft 206.
Various portions of plug assembly 300 are shown in
Plug 308 has a body that extends from a proximal end 309 to a distal end 310, and may include a bevel 311 at distal end 310. In some examples, the bevel 311 may be a solid member (having no lumens or extensions therethrough) in order to seal an opening created through a wall of a blood vessel. Proximal end 309 may include a generally cylindrical portion 315 configured receive a distal end of shaft 306 in a lumen 313. Distal tip 308 also may include a circumferential flange 312 configured to abut flange 116 of inner assembly 100. Lumen 313 may extend from proximal end 309 toward distal end 310, and may be closed off at a distal end by a proximal surface of bevel 311. Plug 308 also may include one or more openings 324 extending through cylindrical portion 315 and in communication with lumen 313. In one example, plug 308 may include diametrically opposed openings 324 that align with openings 310 of shaft 306. Plug 308 also may include a locking protrusion 330 extending radially outward from a proximalmost portion of the bevel 311. As shown in
Distal tip 308 may be coupled to a distal end of shaft 306 via a connecting member 130 that is substantially similar to the connecting member 130 previously described. The connecting member 130 may extend through openings 324 of plug 308 and at least partially around a circumference of cylindrical portion 315. The ends 132 of the connecting member 130 then may be passed through openings 310 of shaft 306, a lumen of shaft 306, and proximally out of shaft 306.
All or portions of inner assembly 100, outer assembly 200, and plug assembly 300 may be formed from biocompatible materials. Examples of such materials may include, but are not limited to, polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), ethylene tetrafluoroethylene (ETFE), polyethylene terephthalate (PET), perfluoroalkoxy (PFA), polyether ether ketone (PEEK), polypropylene (PP), silicone, polycarbonate, polyurethane, LDPE, HDPE or the like. In some embodiments, one or more portions of the inner assembly 100, outer assembly 200, and plug assembly 300, may be formed from bioresorbable materials, including, for example, polyglycolide (PGA), polylactide (PLA), and/or polycaprolactone (PCL). When bioresorbable materials are used, different bioresorbable materials may be used that regrade at different rates. In one example, one or more of piercing tip 108, distal tip 208, and plug 308 may include a bioresorbable material.
Distal tip 208 and piercing tip 108 may have corresponding features that cooperate to secure distal tip 208 and piercing tip 108 together. For example, locking arm 120 of inner assembly 100 may be configured to engage proximal end 209 of distal tip 208. For example, distal tip 208 may be advanced distally over piercing tip 108 until locking arm 120 clears proximal end 209 of distal tip 208, causing distal tip 208 and piercing tip 108 to form a locked configuration relative to one another. The protrusion 121 of locking arm 120 may engage proximal end 209 of distal tip 208. Also, locking arm 120 may be a cantilevered arm that may flex radially inward and outward during engagement with distal tip 208. Once locking arm 120 clears proximal end 209, piercing tip 108 may be prevented from moving distally relative to distal tip 208 due to the engagement of locking arm 120 with proximal end 209 of distal tip 208.
Piercing tip 108 and plug 308 also may have corresponding features that cooperate to secure piercing tip 108 to plug 308. For example, piercing tip 108 includes a recess 122 configured to receive locking protrusion 330 of plug 308. Also, flange 116 of piercing tip 108 may be configured to abut the distally-facing surface of flange 312. Thus, in some examples, plug 308 may be advanced distally through the proximal end 109 of piercing tip 108 until locking protrusion 330 engages with recess 122. Once locking protrusion 330 engages with recess 122, plug 308 may be prevented from moving proximally relative to piercing tip 108 due to the engagement of locking protrusion 330 and recess 122. In some examples, the engagement of locking protrusion 330 with recess 122 may require precise circumferential alignment between piercing tip 108 and plug 308. Additionally, plug 308 may be prevented from moving distally relative to piercing tip 108 due to the engagement of flange 116 and flange 312.
Referring to
Referring to
Once piercing tip 108 and distal tip 208 are secured to one another, dilator 400 and guidewire 500 may be removed from a lumen of inner assembly 100 (
After completion of the procedure, the tools used during the procedure may be removed from blood vessel 1000, and plug assembly 300 may be inserted through inner assembly 100 (
Once piercing tip 108, distal tip 208, and plug 308 are engaged with one another, shafts 106, 206, and 306 may be removed by pulling on connecting member ends 132 as described above. Thus, after completion of the procedure, a closure device comprising only piercing tip 108, distal tip 208, and plug 308 may remain coupled to the blood vessel wall 1002. In some examples, the entirety of the closure device may resorb within 30 to 90 days. In other examples, where the components of the closure device are non-resorbable, the closure device may be removed in a subsequent procedure, if desired.
In an alternative example shown in
In another example shown in
In yet another example shown in
As shown in
As shown in
After insertion of tip 608 within the blood vessel, and pulling back of tip 608, part 612a will snag against the inner surface of the vessel wall, causing part 612a to pivot relative to part 612b and assume the second implanted configuration shown in
Embodiments of the present disclosure may increase the speed of access into the neck for stroke treatments, and also speed up procedural times during other procedures, such as, e.g., femoral access. The angled shape of piercing tip 108 may allow for access into an artery (or other blood vessel) and provide a larger footprint for inside artery securement.
Although the exemplary embodiments described above have been disclosed in connection with medical devices for insertion into a blood vessel, those skilled in the art will understand that the principles set out above can be applied to any body lumen and can be implemented in different ways without departing from the scope of the disclosure as defined by the claims. In particular, constructional details, including manufacturing techniques and materials, are well within the understanding of those of skill in the art and have not been set out in any detail here. These and other modifications and variations are well within the scope of the present disclosure and can be envisioned and implemented by those of skill in the art.
Other exemplary embodiments of the present disclosure will be apparent to those skilled in the art from consideration of the specification and practice of the exemplary embodiments disclosed herein. It is intended that the specification and examples be considered as exemplary only, and departures in form and detail may be made without departing from the scope and spirit of the present disclosure as defined by the following claims.
This patent application is a continuation application of U.S. application Ser. No. 16/480,549, filed on Jul. 24, 2019, which is a national phase entry under 35 U.S.C. § 371 of International PCT Patent Application No. PCT/US2018/014766, filed Jan. 23, 2018, which claims the benefits of priority under 35 U.S.C. § 119 to U.S. Provisional Application No. 62/450,257, filed Jan. 25, 2017, and to U.S. Provisional Application No. 62/525,839, filed Jun. 28, 2017, the entireties of each of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2690595 | Raiche | Oct 1954 | A |
3367101 | Harold et al. | Feb 1968 | A |
3435826 | Fogarty | Apr 1969 | A |
3970090 | Loiacono | Jul 1976 | A |
4224929 | Furihata | Sep 1980 | A |
4403612 | Fogarty | Sep 1983 | A |
4445897 | Ekbladh et al. | May 1984 | A |
4794931 | Yock | Jan 1989 | A |
4857045 | Rydell | Aug 1989 | A |
4886061 | Fischell et al. | Dec 1989 | A |
4894051 | Shiber | Jan 1990 | A |
4898575 | Fischell et al. | Feb 1990 | A |
4926858 | Gifford, III et al. | May 1990 | A |
4936835 | Haaga | Jun 1990 | A |
4950277 | Farr | Aug 1990 | A |
4957482 | Shiber | Sep 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4986807 | Farr | Jan 1991 | A |
5000185 | Yock | Mar 1991 | A |
5000734 | Boussignac et al. | Mar 1991 | A |
5007896 | Shiber | Apr 1991 | A |
5019088 | Farr | May 1991 | A |
5024651 | Shiber | Jun 1991 | A |
5026384 | Farr et al. | Jun 1991 | A |
5087265 | Summers | Feb 1992 | A |
5100425 | Fischell et al. | Mar 1992 | A |
5135531 | Shiber | Aug 1992 | A |
5176693 | Pannek, Jr. | Jan 1993 | A |
5292332 | Lee | Mar 1994 | A |
5313949 | Yock | May 1994 | A |
5314438 | Shturman | May 1994 | A |
5318576 | Plassche, Jr. et al. | Jun 1994 | A |
5336234 | Vigil et al. | Aug 1994 | A |
5366464 | Belknap | Nov 1994 | A |
5395311 | Andrews | Mar 1995 | A |
5402790 | Jang et al. | Apr 1995 | A |
5409454 | Fischell et al. | Apr 1995 | A |
5415634 | Glynn et al. | May 1995 | A |
5419761 | Narayanan et al. | May 1995 | A |
5507292 | Jang et al. | Apr 1996 | A |
5554119 | Harrison et al. | Sep 1996 | A |
5709701 | Parodi | Jan 1998 | A |
5820595 | Parodi | Oct 1998 | A |
5897567 | Ressemann et al. | Apr 1999 | A |
5951514 | Sahota | Sep 1999 | A |
5972019 | Engelson et al. | Oct 1999 | A |
6010522 | Barbut et al. | Jan 2000 | A |
6146370 | Barbut | Nov 2000 | A |
6206868 | Parodi | Mar 2001 | B1 |
6302908 | Parodi | Oct 2001 | B1 |
6336933 | Parodi | Jan 2002 | B1 |
6344054 | Parodi | Feb 2002 | B1 |
6413235 | Parodi | Jul 2002 | B1 |
6423032 | Parodi | Jul 2002 | B2 |
6494890 | Shturman et al. | Dec 2002 | B1 |
6540712 | Parodi et al. | Apr 2003 | B1 |
6595980 | Barbut | Jul 2003 | B1 |
6623471 | Barbut | Sep 2003 | B1 |
6626861 | Hart et al. | Sep 2003 | B1 |
6641573 | Parodi | Nov 2003 | B1 |
6645222 | Parodi et al. | Nov 2003 | B1 |
6824558 | Parodi | Nov 2004 | B2 |
6827726 | Parodi | Dec 2004 | B2 |
6837881 | Barbut | Jan 2005 | B1 |
6855162 | Parodi | Feb 2005 | B2 |
6902540 | Dorros et al. | Jun 2005 | B2 |
6905490 | Parodi | Jun 2005 | B2 |
6908474 | Hogendijk et al. | Jun 2005 | B2 |
6929634 | Dorros et al. | Aug 2005 | B2 |
6936053 | Weiss | Aug 2005 | B1 |
6936060 | Hogendijk et al. | Aug 2005 | B2 |
6974469 | Broome et al. | Dec 2005 | B2 |
7195611 | Simpson et al. | Mar 2007 | B1 |
7214201 | Burmeister et al. | May 2007 | B2 |
7235095 | Haverkost et al. | Jun 2007 | B2 |
7309334 | Hoffmann | Dec 2007 | B2 |
7384411 | Condado | Jun 2008 | B1 |
7604612 | Ressemann et al. | Oct 2009 | B2 |
7806906 | Michael | Oct 2010 | B2 |
7867273 | Pappas et al. | Jan 2011 | B2 |
7901445 | Wallace et al. | Mar 2011 | B2 |
7918800 | Brown et al. | Apr 2011 | B1 |
7927347 | Hogendijk et al. | Apr 2011 | B2 |
8123779 | Demond et al. | Feb 2012 | B2 |
8157760 | Criado et al. | Apr 2012 | B2 |
8267956 | Salahieh et al. | Sep 2012 | B2 |
8353850 | Ressemann et al. | Jan 2013 | B2 |
8409237 | Galdonik et al. | Apr 2013 | B2 |
8414516 | Chang | Apr 2013 | B2 |
8439937 | Montague et al. | May 2013 | B2 |
8545432 | Renati et al. | Oct 2013 | B2 |
8834404 | Beaudin | Sep 2014 | B2 |
8852226 | Gilson et al. | Oct 2014 | B2 |
8863631 | Janardhan et al. | Oct 2014 | B1 |
9078682 | Lenker et al. | Jul 2015 | B2 |
9241699 | Kume et al. | Jan 2016 | B1 |
9259215 | Chou et al. | Feb 2016 | B2 |
9265512 | Garrison et al. | Feb 2016 | B2 |
9987164 | Calhoun et al. | Jun 2018 | B2 |
10195077 | Calhoun et al. | Feb 2019 | B2 |
10265085 | Zaidat | Apr 2019 | B2 |
10342699 | Calhoun et al. | Jul 2019 | B2 |
20010001114 | Tsugita et al. | May 2001 | A1 |
20020038103 | Estrada et al. | Mar 2002 | A1 |
20020077656 | Ginn et al. | Jun 2002 | A1 |
20020077658 | Ginn | Jun 2002 | A1 |
20020087128 | Paques et al. | Jul 2002 | A1 |
20020143291 | Slater | Oct 2002 | A1 |
20020151922 | Hogendijk et al. | Oct 2002 | A1 |
20020165573 | Barbut | Nov 2002 | A1 |
20030023200 | Barbut et al. | Jan 2003 | A1 |
20030023227 | Zadno-Azizi et al. | Jan 2003 | A1 |
20030199802 | Barbut | Oct 2003 | A1 |
20030199819 | Beck | Oct 2003 | A1 |
20030203958 | Kunz et al. | Oct 2003 | A1 |
20050149117 | Khosravi et al. | Jul 2005 | A1 |
20060089618 | McFerran et al. | Apr 2006 | A1 |
20060136022 | Wong et al. | Jun 2006 | A1 |
20060259132 | Schaffer et al. | Nov 2006 | A1 |
20060276838 | Wensel et al. | Dec 2006 | A1 |
20070026035 | Burke et al. | Feb 2007 | A1 |
20080027519 | Guerrero | Jan 2008 | A1 |
20080243229 | Wallace et al. | Oct 2008 | A1 |
20090018455 | Chang | Jan 2009 | A1 |
20090024072 | Criado et al. | Jan 2009 | A1 |
20090030323 | Fawzi et al. | Jan 2009 | A1 |
20090221961 | Tal et al. | Sep 2009 | A1 |
20100076365 | Riina et al. | Mar 2010 | A1 |
20100100045 | Pravongviengkham et al. | Apr 2010 | A1 |
20100125244 | McAndrew | May 2010 | A1 |
20100234884 | Lafontaine et al. | Sep 2010 | A1 |
20110082495 | Ruiz | Apr 2011 | A1 |
20110143993 | Langer et al. | Jun 2011 | A1 |
20110152683 | Gerrans et al. | Jun 2011 | A1 |
20110152998 | Berez et al. | Jun 2011 | A1 |
20110160762 | Hogendijk et al. | Jun 2011 | A1 |
20110274748 | Robinson et al. | Nov 2011 | A1 |
20120046679 | Patel et al. | Feb 2012 | A1 |
20120078287 | Barbut | Mar 2012 | A1 |
20120101510 | Lenker et al. | Apr 2012 | A1 |
20130035628 | Garrison et al. | Feb 2013 | A1 |
20130197621 | Ryan et al. | Aug 2013 | A1 |
20130281788 | Garrison | Oct 2013 | A1 |
20140154246 | Robinson et al. | Jun 2014 | A1 |
20140222066 | Tegels | Aug 2014 | A1 |
20150025562 | Dinh et al. | Jan 2015 | A1 |
20150032121 | Janardhan et al. | Jan 2015 | A1 |
20150065804 | Kleyman | Mar 2015 | A1 |
20150231378 | Pepper | Aug 2015 | A1 |
20150272732 | Tilson et al. | Oct 2015 | A1 |
20150313607 | Zhadkevich | Nov 2015 | A1 |
20150359547 | Vale et al. | Dec 2015 | A1 |
20150359549 | Lenker et al. | Dec 2015 | A1 |
20150366580 | Lenihan et al. | Dec 2015 | A1 |
20160166754 | Kassab et al. | Jun 2016 | A1 |
20160213893 | Franklin | Jul 2016 | A1 |
20160279385 | Katsurada et al. | Sep 2016 | A1 |
20160317328 | Berez et al. | Nov 2016 | A1 |
20170164963 | Goyal | Jun 2017 | A1 |
20170239453 | Kawakita et al. | Aug 2017 | A1 |
20170274179 | Sullivan et al. | Sep 2017 | A1 |
20170326001 | Franco et al. | Nov 2017 | A1 |
20170348120 | Calhoun et al. | Dec 2017 | A1 |
20180132876 | Zaidat | May 2018 | A1 |
20190192164 | Parekh et al. | Jun 2019 | A1 |
20190388112 | Nguyen et al. | Dec 2019 | A1 |
Number | Date | Country |
---|---|---|
2495006 | Sep 2012 | EP |
9852939 | Nov 1998 | WO |
9853761 | Dec 1998 | WO |
0054673 | Sep 2000 | WO |
03018085 | Mar 2003 | WO |
2007103464 | Sep 2007 | WO |
2011156782 | Dec 2011 | WO |
2012162651 | Nov 2012 | WO |
2014022866 | Feb 2014 | WO |
2016109586 | Jul 2016 | WO |
2016149653 | Sep 2016 | WO |
2017156333 | Sep 2017 | WO |
2018053121 | Mar 2018 | WO |
2018106858 | Jun 2018 | WO |
Entry |
---|
Altinbas, N.K. et al., “Effect of Carotid Artery Stenting on Ophthalmic Artery Flow Patterns,” Journal of Ultrasound Medicine, 2014; 33: pp. 629-638. |
Ambarki, K. et al., “Blood Flow of Ophthalmic Artery in Healthy Individuals Determined by Phase-Contrast Magnetic Resonance Imaging,” Investigative Ophthalmology & Visual Science, 2013; 54: pp. 2738-2745. |
Aurboonyawat et al., “Indirect Carotid-Cavernous Sinus Fistulas Treated by Transvenous Approach Through the Superior Ophthalmic Vein: A Case Report and Technical Note,” Siriraj Med. J., vol. 59, pp. 191-194, 2007. |
Bird, B. et al., “Anatomy, Head and Neck, Ophthalmic Arteries,” NCBI Bookshelf, a service of the National Library of Medicine, National Institutes of Health, Oct. 27, 2018, 5 pages. www.ncbi.nlm.nih.gov/books/NBK482317/. |
Examination Report No. 2 for AU Application No. 2013296195, dated Jun. 27, 2017 (6 pages). |
Extended European Search Report for EP 18745369.1, dated Nov. 18, 2020 (6 pages). |
Hattenbach, L. et al., “Experimental Endoscopic Endovascular Cannulation: A Novel Approach to Thrombolysis in Retinal Vessel Occlusion,” Investigative Ophthalmology & Visual Science, Jan. 2012, vol. 53, No. 1, pp. 42-46. |
Hayreh et al., “Ocular Arterial Occlusive Disorders and Carotid Artery Disease,” American Academy of Ophthalmology, 2017; vol. 1, No. 1: pp. 12-18. |
Hayreh et al., “The Ophthalmic Artery,” Brit. J. Ophthal., 1962; 46, 65: pp. 65-98. |
Hayreh, S.S., “The Ophthalmic Artery III. Branches,” British Journal of Ophthalmology, 1962, 46, pp. 212-247. |
Wang, G. et al., “Reversal of Ischemic Retinopathy Following Balloon Angioplasty of a Stenotic Ophthalmic Artery.” Journal of Neuro-Ophthalmology 30.3, 2010, pp. 228-230. |
International Search Report and Written Opinion for corresponding PCT/US2013/053670, dated Dec. 26, 2013 (16 pp.). |
International Search Report and Written Opinion for International Application No. PCT/US2017/0051551, dated Dec. 15, 2017 (14 pages). |
International Search Report and Written Opinion for International Application No. PCT/US2017/0052901, dated Dec. 8, 2017 (9 pages). |
International Search Report and Written Opinion for International Application No. PCT/US2018/031229, dated Jul. 27, 2018 (19 pages). |
International Search Report and Written Opinion for International Application No. PCT/US2019/068758, dated May 29, 2020 (16 pages). |
Kane, A.G. et al., “Reduced Caliber of the Internal Carotid Artery: A Normal Finding with Ipsilateral Absence or Hypoplasia of the A1 Segment,” American Journal of Neuroradiology, 1996; 17: pp. 1295-1301. |
Kawa, M.P. et al., “Complement System in Pathogenesis of AMD: Dual Player in Degeneration and Protection of Retinal Tissue,” Hindawi Publishing Corporation, Journal of Immunology Research, vol. 2014, Article ID 483960, 12 pages. |
Khan, T.T. et al., “An Anatomical Analysis of the Supratrochlear Artery: Considerations in Facial Filler Injections and Preventing Vision Loss,” Aesthetic Surgery Journal, 2017, vol. 37(2), pp. 203-208. |
Klein, R. et al., “Vasodilators, Blood Pressure-Lowering Medications, and Age-Related Macular Degeneration,” American Academy of Ophthalmology, 2014, vol. 121, Issue 8, pp. 1604-1611. |
Kleintjes, “Forehead anatomy: Arterial variations and venous link of the midline forehead flap,” Journal of Plastic, Reconstructive & Aesthetic Surgery, vol. 60, Issue 6, pp. 593-606, 2007. |
Kooragayala, K. et al., “Quanitification of Oxygen Consumption in Retina Ex Vivo Demonstrates Limited Reserve Capacity of Photoreceptor Mitochondria,” Investigative Ophthalmology & Visual Science, 2015; 56: pp. 8428-8436. |
Krejza, J. et al., “Carotid Artery Diameter in Men and Women and the Relation to Body and Neck Size,” Stroke, 2006; 3 pages. |
Lanzino, G. et al., “Treatment of Carotid Artery Stenosis: Medical Therapy, Surgery, or Stenting?,” Mayo Clinic Proceedings, Apr. 2009; 84(4), pp. 362-368. |
Loh, K. et al., “Prevention and management of vision loss relating to facial filler injections.” Singapore Medical Journal, 2016; 57(8): 438-443. |
Mazur et al., Catheterization and Cardiovascular Diagnosis, vol. 31, Issue 1, Abstract (1994). |
Michalinos, A. et al., “Anatomy of the Ophthalmic Artery: A Review concerning Its Modern Surgical and Clinical Applications,” Hindawi Publishing Corporation, Anatomy Research International, vol. 2015, Article ID 591961, 8 pages. |
Notice of Allowance for KR 20157005602, dated Sep. 25, 2017 (3 pages). |
Paques, M. et al., “Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion.” British Journal of Ophthalmology, 2000, 84: 1387-1391. |
Schumacher, M. et al., “Intra-arterial fibrinolytic therapy in central retinal artery occlusion,” Neuroradiology (1993) 35: pp. 600-605. |
Schwenn, O.K. et al., “Experimental Percutaneous Cannulation of the Supraorbital Arteries: Implication for Future Therapy,” Investigative Ophthalmology & Visual Science, May 2005, vol. 46, No. 5, pp. 1557-1560. |
Tan, P.L. et al., “AMD and the alternative complement pathway: genetics and functional implications,” Human Genomics, 2016, 10:23, 13 pages. |
Wang, R. et al., “Evaluation of Ophthalmic Artery Branch Retrograde Intervention in the Treatment of Central Retinal Artery Occlusion (CRAO),” Medical Science Monitor, 2017, 23: pp. 114-120. |
Written Opinion and International Search Report dated Mar. 29, 2018, of International Patent Application No. PCT/US2018/14766. (7 pages). |
Xu, H. et al., “Targeting the complement system for the management of retinal inflammatory and degenerative diseases,” European Journal of Pharmacology, 2016, 787, pp. 94-104. |
Yamane, T. et al., “The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma,” International Journal of Clinical Oncology, Apr. 2004; vol. 9, Issue 2, pp. 69-73. |
Zeumer, H. et al., “Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plagminogen activator (r-TPA),” Neuroradiology, 1993; 35: pp. 159-162. |
Zhao, W. et al. “Three-Dimensional Computed Tomographic Study on the Periorbital Branches of the Ophthalmic Artery: Arterial Variations and Clinical Relevance,” Aesthetic Surgery Journal, 2018, pp. 1-9. |
Zipfel, P.F., et al., “The Role of Complement in AMD,” Inflammation and Retinal Disease: Complement Biology and Pathology, Advances in Experimental Medicine and Biology, 2010, 703, pp. 9-24. |
Number | Date | Country | |
---|---|---|---|
20230149004 A1 | May 2023 | US |
Number | Date | Country | |
---|---|---|---|
62525839 | Jun 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16480549 | US | |
Child | 18054412 | US |